What is the price target for TCBP stock?
7 analysts have analysed TCBP and the average price target is 48.96 USD. This implies a price increase of 9692% is expected in the next year compared to the current price of 0.5.

NASDAQ:TCBP • US87807D6085
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TC BIOPHARM HOLDINGS PLC-ADR (TCBP).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-12-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-27 | HC Wainwright & Co. | Maintains | Buy |
| 2023-01-26 | HC Wainwright & Co. | Initiate | Buy |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.98M -42.27% | 1.98M | 3.84M 93.94% | 2.018M -100.00% | |||
| EBITDA YoY % growth | -5.82M -2.46% | -6.29M -8.08% | -10.95M -74.09% | N/A -24.26% | N/A | N/A | |
| EBIT YoY % growth | -6.89M -4.71% | -7.31M -6.10% | -11.92M -63.06% | -24.094M -19.46% | -13.813M 2.99% | -14.484M -4.86% | |
| Operating Margin | -347.98% | -369.19% | -310.42% | -1,193.98% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -4.69 99.99% | -0.16 96.52% | 0.00 100.00% |
All data in GBP
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.81 99.93% | -0.71 99.94% | N/A | 0.00 100.00% | 0.00 100.00% | 0.00 100.00% | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Q2Q % growth | 504.9K | 504.9K -86.87% | N/A | -100.00% | -100.00% | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.514M -8.01% | -5.616M 52.89% | N/A | -3.366M 56.20% | -3.443M 37.57% | -3.494M 37.80% | -3.545M | -3.596M -6.82% | -3.825M -11.11% | -3.698M -5.84% |
All data in GBP
7 analysts have analysed TCBP and the average price target is 48.96 USD. This implies a price increase of 9692% is expected in the next year compared to the current price of 0.5.
TC BIOPHARM HOLDINGS PLC-ADR (TCBP) will report earnings on 2022-12-13, before the market open.
The consensus EPS estimate for the next earnings of TC BIOPHARM HOLDINGS PLC-ADR (TCBP) is -0.81 USD and the consensus revenue estimate is 504.90K USD.